sur Repair Biotechnologies, Inc.
Repair Biotechnologies Announces Appointment of Noted Cardiologists to Scientific Advisory Board
SYRACUSE, NY / ACCESSWIRE / July 3, 2024 / Repair Biotechnologies, Inc. has announced the appointments of Ronald P. Karlsberg, MD, FACC, MSCCT, FAHA, FACP, and Daniel Karlsberg, MD, FACC, FSCCT to its Scientific Advisory Board (SAB). The SAB includes experts in cardiology, the biochemistry of atherosclerosis, and related immunology.
The CEO of Repair Biotechnologies, Reason, stated that Drs. Ronald and Daniel Karlsberg will be instrumental in advancing the company's novel approach to treating atherosclerosis, aiming to regress arterial plaque significantly. Both doctors emphasize the importance of personalized approaches in cardiology to address the earliest stages of plaque development.
Dr. Ronald Karlsberg, a Clinical Professor at Cedars-Sinai Heart Institute and UCLA, specializes in clinical and preventive cardiology. He is recognized for innovative medical therapies and translational research. Dr. Daniel Karlsberg, board-certified in internal medicine and cardiovascular disease, is currently on the clinical faculty at NYU Langone Health.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Repair Biotechnologies, Inc.